Ipratropium bromide (Univent), solution 250 mcg per ml, 1 ml ampoule: Discontinuation

Discontinuation Active

Ipratropium bromide, nebuliser soln, 250 mcg per ml, 1 ml ampoule (Univent) is used as short-term acute treatment for the reversible component in chronic obstructive airways diseases, such as chronic bronchitis and bronchial asthma.

We understand that Univent is usually used in a hospital setting but that it may also used in primary care. 

1 ml ampoule presentation of Univent is being discontinued 

At the end of December 2020 Rex Medical will stop supplying Univent (ipratropium bromide, nebuliser soln, 250 mcg per ml, 1 ml ampoule).

What PHARMAC is doing

We requested clinical advice from our Respiratory Subcommittee. They advised that Univent (ipratropium bromide, nebuliser soln, 250 mcg per ml, 2 ml ampoule) would be a suitable alternative for people using the 1ml ampoule presentation.    

The 2 ml ampoule presentation of Univent will continue to be available after the end of December 2020.

Information for people using the 1 ml ampoule of Univent

Unfortunately, the supplier will stop supplying the 1ml ampoule presentation of Univent (ipratropium bromide, nebuliser solution 250 mcg per ml) at the end of December 2020.

Talk to your prescriber about an alternative treatment that is right for you.

We know that changing your medicine can be disruptive. Thank you for your understanding.

Information for prescribers

If you decide that the 2 ml ampoule presentation is the best alternative, please ensure that your patient knows how to check the dose is correct if they are self-administering Univent.

We appreciate the work you do to support patients through changes in medication. 

Information for pharmacists

This discontinuation affects the 1 ml ampoule of ipratropium bromide, nebuliser soln, 250 mcg per ml, Pharmacode 2154293.

Rex Medical advises that stock of Univent 1 ml ampoule will expire on 31 December 2020. Stock is available on sale or return conditions via the wholesaler.

The Univent 1 ml ampoule presentation will be delisted from the Pharmaceutical Schedule on 1 January 2021. 

Who to contact 

If you are using the Univent 1 ml ampoule presentation talk to a prescriber. PHARMAC cannot advise on individual clinical circumstances.

If you have questions about the discontinuation, contact the supplier Rex Medical (0800 739 633)

If you have any other questions contact enquiry@pharmac.govt.nz